Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2026-01-02 @ 10:56 PM
Study NCT ID:
NCT05266456
Status:
COMPLETED
Last Update Posted:
2024-04-18
First Post:
2022-02-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults
Sponsor:
Vaxcyte, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
VAX24-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None